For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240802:nRSB9808Ya&default-theme=true
RNS Number : 9808Y B.P. Marsh & Partners PLC 02 August 2024
2 August 2024
B.P. Marsh & Partners Plc
("B.P. Marsh" or "the Company")
Share Buy-Back Programme Update
B.P. Marsh, the niche venture capital provider to early stage financial
services businesses, announces that, further to the announcement of its Share
Buy-Back Programme on 11 June 2024, the Company has agreed to revise the
maximum purchase price under this programme to enable it to purchase shares up
to a price representing a discount of at least 10% to the most recently
announced diluted NAV per share.
This is a reduction from the previous policy which had a limit representing a
15% discount to the diluted NAV per share.
All other terms of the Share Buy-Back Programme set out in the announcement on
11 June 2024 remain unchanged.
For further
information:
B.P. Marsh & Partners Plc www.bpmarsh.co.uk (http://www.bpmarsh.co.uk/)
Brian Marsh OBE +44 (0)20 7233 3112
Nominated Adviser & Broker
Panmure Liberum Limited
Atholl Tweedie / Amrit Mahbubani / Ailsa MacMaster +44 (0)20 7886 2500
Financial PR & Investor Relations
Tavistock bpmarsh@tavistock.co.uk
Simon Hudson / Tim Pearson / Katie Hopkins +44 (0)20 7920 3150
Notes to Editors:
B.P. Marsh's current portfolio contains fifteen companies. More detailed
descriptions of the portfolio can be found at www.bpmarsh.co.uk
(http://www.bpmarsh.co.uk/) .
Since formation over 30 years ago, the Company has assembled a management team
with considerable experience both in the financial services sector and in
managing private equity investments. Many of the directors have worked with
each other in previous roles, and all have worked with each other for over ten
years.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCUUSBRSAUWRRR